Stories

A Plea for New Coding

in

Coding flaws are causing big problems for oncologists across the country. You know it, we know it. Improper and decreased reimbursements are leaving little choice but for small practices to close.

Flaws In Medicare Coding Interpretations

in

We work with medical oncologists/hematologists across the country in both the private practice and hospital settings.

AMA Rejects Request For New Hem/Onc CPT Codes

in

Neltner Billing and Consulting recently submitted documents to the AMA suggesting that the infusion coding oncology and hematology rely on for appropriate payment of professional physician work and

Neltner Abstract Accepted by ASCO

in

Neltner Billing and Consulting is honored that the American Society of Clinical Oncology accepted our abstract, "An Examination of Oncology Drug Purchasing Compared to Average Sales Price" for onli

Neltner Abstract Accepted by ASCO

in

Neltner Billing and Consulting is honored that the American Society of Clinical Oncology accepted our abstract, "An Examination of Oncology Drug Purchasing Compared to Average Sales Price" for onli

Persistence Pays Off: A Success Story Worth Discussing

in

On behalf of a client, we have a great success story to report. One of our oncology clients was having continued denials with a large private pay insurance company.

Reality is in the Results, and It Is No Surprise: Your ASP Tallies

in

In a recent Neltner News article, we asked for you to complete our short ASP "worksheet".

Procrit and Aranesp: CMS Denies Reimbursement with New Policy

in

The Centers for Medicare & Medicaid Services (CMS) recently implemented a change in the coverage of two necessary drugs used in conjunction with the treatment of cancer.

Neltner Billing Now Has Oncology Benchmark Data

in

Neltner Billing and Consulting has recently created oncology benchmark data that are based on financial analyses of 13 oncology practices across the country.

Syndicate content